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Abstract
Introduction: Kerosene is a freely accessible hydrocarbon used in Sri Lankan (and other Asian) households for
cooking and for lighting lamps. Kerosene poisoning is rarely reported among adults and its toxicological effects are
not well known. Metformin is a commonly used oral hypoglycemic drug and its overdose leads primarily to lactic
acidosis. Combined poisoning of metformin and kerosene and their interactions have not been reported.
Case presentation: An 18-year-old, previously healthy, unmarried Sinhalese woman was referred following
ingestion of 17.5 g of metformin and approximately 200 mL of kerosene oil in a suicide attempt. She had
vomiting, burning epigastric pain, and a hypoglycemic seizure (capillary blood glucose of 42 mg/dL). Subsequently,
she developed severe lactic acidosis followed by acute renal insufficiency, was treated with sodium bicarbonate,
and underwent intermittent hemodialysis with bicarbonate. She recovered completely.
Conclusions: This report proposes possible interactions that occur between metformin and kerosene that
augment toxicity when the two are ingested together. It also stresses the importance of early treatment with
intermittent hemodialysis in severe lactic acidosis with maintenance of blood glucose.
Introduction
Metformin is one of the commonest drugs used as a
treatment of type 2 diabetes mellitus and in insulin
resistance states such as polycystic ovarian syndrome.
Lactic acidosis is a recognized complication of pharma-
cological doses of the drug, mostly in those with chronic
renal failure, and has a frequency of 0.01 to 0.08 per
1000 patient-years [1]. Overdose with metformin leads
to severe lactic acidosis and fatalities. The pathogenesis
is not well known.
Kerosene is a freely accessible hydrocarbon used in Sri
Lankan (and other Asian) households for cooking and
for lighting lamps. It is also used as a solvent of many
substances, including pesticides. Kerosene poisoning is
rarely reported among adults, although epidemiological
studies indicate high rates of hydrocarbon poisoning. Its
effect on kidneys is not well documented and is likely to
lead to acute tubular necrosis [2].
There is a debate in the literature about lactic acidosis
caused by pharmacological doses of metformin. A study
found that metformin, despite concerns to the contrary,
is not associated with an increased risk for lactic acido-
sis compared with other anti-hyperglycemic treatments,
whereas others have reported a low incidence of lactic
acidosis in those on metformin [3]. However, metformin
is well known to cause lactic acidosis after an overdose
[4]. We report a case of metformin and kerosene toxi-
city with hypoglycemia, severe acidosis, and renal failure
and suggest the possibility of pharmacokinetic and
metabolic interactions to explain acidosis observed in
our patient.
Case presentation
An 18-year-old, previously healthy, unmarried Sinhalese
woman from a nearby city (20 km away from Colombo)
was referred to a tertiary care hospital in Colombo for
treatment of metabolic acidosis after an overdose of 35
tablets of metformin (17.5 g) and a quarter bottle
(nearly 200 mL) of kerosene oil. She was admitted to a
local hospital a few hours after ingestion and was
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developed a generalized tonic clonic seizure that lasted
five minutes. When she was admitted to the teaching
hospital, her capillary blood sugar level had been 42
mg/dL and was treated with a bolus intravenous dex-
trose and 10% dextrose infusion. Her arterial blood gas
(ABG) revealed a severe metabolic acidosis (Table 1).
She was treated with two doses of 75 mL of 8.4%
sodium bicarbonate (NaHCO3) (75 mmol) but had per-
sisting acidosis three hours later. At that stage, she was
given 50 mL of NaHCO3 (50 mmol), 500 mg ampicillin,
and 50 mg ranitidine (all intravenously) and was trans-
ferred to a Tertiary care hospital, Colombo (THC) for
hemodialysis.
At THC, she complained of burning epigastric pain
and shortness of breath. She also had several episodes of
vomiting. Her peripheries were warm. She had Kuss-
maul breathing and a respiratory rate of 44/minute, a
pulse rate of 116/minute, and a blood pressure of 90/60
mm Hg. Except for the mild epigastric tenderness, the
results of the rest of a physical examination were nor-
mal. Her oxygen saturation was 92% with 5 L/minute
oxygen via a face mask. The ABG at 15 hours after
ingestion showed continuing acidosis with a high anion
g a p( T a b l e1 ) .H e rs e r u ml a c t a t el e v e lw a se l e v a t e da t
59.96 mg/dL.
Eighteen hours after ingestion, she was started on
intermittent hemodialysis with bicarbonate buffer
(which contains both solutions A and B) (Additional file
1). The initial dialysis was continued only for two and a
half hours with a blood flow rate of 140 mL/minute and
a dialysate flow rate of 500 mL/minute. However, she
continued to be acidotic four hours after the dialysis
(that is, 28 hours after ingestion). She was treated again
with 8.4% NaHCO3 (100 mL), and dialysis was repeated
on the following day. The ABG after the second dialysis
(that is, 48 hours following ingestion) showed compen-
sated metabolic acidosis (Table 1). The serum creatinine
level was 279 μmol/L on admission and started to
increase rapidly two days after admission (Figure 1) and
was accompanied by a declining urine output. Subse-
quently, she was dialyzed on days 3, 10, and 14. All of
the subsequent dialyses were continued for 4 hours with
a blood flow rate of 200 mL/minute and a dialysate flow
rate of 500 mL/minute. Her urine output and renal
functions improved gradually, and after three weeks she
was discharged with normalized renal functions.
Discussion
This case highlights some of the interesting effects of
metformin overdose. Our patient developed lactic acido-
sis, which is well recognized with overdose and carries a
mortality of 50% [5]. In the literature, there is a debate
about lactic acidosis caused by pharmacological doses of
metformin. Salpeter and colleagues [6] reviewed all stu-
dies of metformin treatment from 1966 to August 2005
and found no cases of fatal or nonfatal lactic acidosis.
Also, there was no disparity in lactate levels between
metformin and placebo or other treatment groups. The
authors concluded that there is no evidence that metfor-
min is associated with an increased risk of increased lac-
tate levels or lactic acidosis. The precise pathophysiology
of lactic acidosis in metformin overdose is not well
known. It could be that the drug decreases pyruvate
dehydrogenase (a mitochondrial reducing enzyme) activ-
ity and enhances anaerobic metabolism, which leads to
increased metabolism of pyruvate to lactate [7]. Another
hypothesis is that metformin accumulates in the intes-
tine and increases the production of lactate, which low-
ers the pH within the liver and decreases lactate
metabolism by suppressing pyruvate carboxylase [8]. A
prospective observational study conducted by Arroyo
and colleagues [9] from 2006 to 2010 among 29 patients
on pharmacological doses of metformin revealed that
acute kidney injury is associated with an episode of
volume depletion due to gastrointestinal losses. Simi-
larly, hypotension due to vomiting at the time of admis-
sion in our patient might have contributed to the
severity of metabolic acidosis and acute renal failure.
There are few reports of kerosene toxicity and its
effects on metabolic pathways. Kerosene inhibits cellular
respiration processes of the liver and kidney in vitro.
This leads to an increase in concentration of lactate and
pyruvate in the blood and liver, a decrease in glucose
concentration in the blood, and a reduction of glycogen
content in the liver and in the skeletal muscle and is
Table 1 Arterial blood gas reports
Duration from the time of poisoning
11 hours 15 hours 24 hours 28 hours 48 hours 51 hours 67 hours
pH 7.081 7.167 7.1 7.386 7.42 7.43
Bicarbonate, mmol/L 4 4 < 3 16.5 23.4 21.9
Base excess, mmol/L -25.9 24.4 NA -8.6 -1.1 -2.4
Lactate, mg/dL 59.96
pH and serum bicarbonate levels progressively decreased until 28 hours after self-poisoning and improved gradually with recurrent hemodialysis. NA, not
applicable.
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dehydrogenase activity in the liver [10]. Kerosene
ingestion causes renal tubular necrosis, which could
have led to impaired elimination of metformin, as it
is eliminated primarily via the kidneys with negligi-
ble metabolism [11].
We also hypothesize a synergistic effect of kerosene
and metformin on the cellular respiration to explain the
prolonged hypoglycemia and acidosis in our patient. It
is well known that metformin leads to hypoglycemia
due to decreased hepatic glucose output [12] and
increased glucose utilization by muscles and liver (which
is insulin-mediated) [13]. The inhibition of respiration
by kerosene, described in the previous paragraph, and
the effects of metformin at the cellular level could act
synergistically to result in prolonged hypoglycemia and
increased lactic acid production.
T h em a i n s t a yo ft h e r a p yi n v o lves repairing acid-base
balance, removing causes of lactic acidosis, and suppor-
tive therapy. Hemodialysis with bicarbonate buffer has
been used successfully in the treatment of lactic acidosis
in metformin use [14]. Hemodialysis not only corrects
the acidosis but also efficiently removes metformin from
plasma, preventing further lactate overproduction, and
removes lactate [15].
This case report reiterates the fact that lactic acidosis
can be corrected by the above means as the patient
made a full recovery from acute renal failure. This case
report adds to the series of case reports that have used
hemodialysis as a treatment modality for metformin-
induced lactic acidosis, although hemofiltration is con-
sidered to be the intervention of choice [16]. Bicarbo-
nate buffer too has been used to combat the severe
acidosis from metformin overdose [17].
Conclusions
This case report highlights the relative lack of knowl-
edge in relation to acute human toxicity from two com-
monly used agents. The paper proposes possible
interactions that occur between metformin and kerosene
that augment toxicity when the two are ingested
together. It also stresses the importance of early treat-
ment with intermittent hemodialysis in severe lactic
acidosis with maintenance of blood glucose.
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Additional file 1: Constituents of bicarbonate buffer. The bicarbonate
buffer comes in two solutions, named A and B.
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Figure 1 Change of serum creatinine level over time.
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